Start an analysis for CTVA
Corteva, Inc.
Stock · NYSEProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $3.0bn | 30-Sep-26 | 10-Q filed 12-Nov-26 |
| Remaining authorization | $1.9bn | 30-Sep-26 | 10-Q filed 12-Nov-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $0 | 30-Sep-26 | 10-Q filed 12-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 19-Nov-24 | $3.0bn | $1.9bnEST | n/a | On November 19, 2024, Corteva, Inc. announced that its Board of Directors authorized a $3 billion share repurchase program to purchase Corteva, Inc.’s common stock, par value $0.01 per share, without an expiration date.10-Q filed 12-Nov-26 |
Open-market repurchases
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 0 | — | $0 | 10-Q filed 12-Nov-26 |
| 31-Aug-26 | 0 | — | $0 | 10-Q filed 12-Nov-26 |
| 31-Jul-26 | 0 | — | $0 | 10-Q filed 12-Nov-26 |